AP NEWS
Click to copy
Press release content from ACCESSWIRE. The AP news staff was not involved in its creation.
Click to copy
PRESS RELEASE: Paid content from ACCESSWIRE
Press release content from ACCESSWIRE. The AP news staff was not involved in its creation.

Avinger to Announce First Quarter 2019 Financial Results on May 8, 2019

May 2, 2019
REDWOOD CITY, CA / ACCESSWIRE / May 2, 2019 / Avinger, Inc. (NASDAQ: AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of patients with
REDWOOD CITY, CA / ACCESSWIRE / May 2, 2019 / Avinger, Inc. (NASDAQ: AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of patients with

REDWOOD CITY, CA / ACCESSWIRE / May 2, 2019 / Avinger, Inc. (NASDAQ: AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of patients with Peripheral Artery Disease (PAD), today announced that it will release its financial results for the first quarter 2019 after the close of trading on Wednesday, May 8, 2019. The Company will host a conference call beginning at 1:30pm PT/4:30pm ET.

Individuals interested in listening to the conference call may do so by dialing 844-602-0380 for domestic callers or +1-862-298-0970 for international callers. To listen to a live webcast, please visit http://www.avinger.com and select Investor Relations.

A replay of the call will be available beginning May 8, 2019 at approximately 7:30pm PT/10:30pm ET through May 15, 2019. To access the replay, dial 919-882-2331 and reference Conference ID: 48585. The webcast will also be available on Avinger’s website following completion of the call at www.avinger.com.

About Avinger, Inc.

Avinger is a commercial-stage medical device company that designs and develops the first-ever image-guided, catheter-based system that diagnoses and treats patients with peripheral artery disease (PAD). PAD is estimated to affect over 12 million people in the U.S. and over 200 million worldwide. Avinger is dedicated to radically changing the way vascular disease is treated through its Lumivascular platform, which currently consists of the Lightbox imaging console, the Ocelot family of chronic total occlusion (CTO) catheters, and the Pantheris® family of atherectomy devices. Avinger is based in Redwood City, California. For more information, please visit www.avinger.com.

Investor Contact:

Mark Weinswig

Chief Financial Officer

Avinger, Inc.

(650) 241-7916

ir@avinger.com

Matt Kreps

Darrow Associates Investor Relations

(214) 597-8200

SOURCE: Avinger, Inc.

All contents © copyright 2019 The Associated Press. All rights reserved.